Samantha Budd Haeberlein

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 5

Top Topics

Peritoneal Dialysis

Genome Wide Association

Mild Cognitive Impairment

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Stephanie J Loomis, Ryan Miller, Carmen Castrillo-Viguera, Kimberly Umans, Wenting Cheng, John O'Gorman, Richard Hughes, Samantha Budd Haeberlein, Christopher D Whelan
Genome-Wide Association Studies of ARIA From the Aducanumab Phase 3 ENGAGE and EMERGE Studies. Neurology 102 (3) (2023)
Stephanie J Loomis, Ryan Miller, Carmen Castrillo-Viguera, Kimberly Umans, Wenting Cheng, John O'Gorman, Richard Hughes, Samantha Budd Haeberlein, Christopher D Whelan
Genome-Wide Association Studies of ARIA From the Aducanumab Phase 3 ENGAGE and EMERGE Studies. Neurology 102 (3) (2023)
Stephanie J Loomis, Ryan Miller, Carmen Castrillo-Viguera, Kimberly Umans, Wenting Cheng, John O'Gorman, Richard Hughes, Samantha Budd Haeberlein, Christopher D Whelan
Genome-Wide Association Studies of ARIA From the Aducanumab Phase 3 ENGAGE and EMERGE Studies. Neurology 102 (3) (2023)
Stephanie J Loomis, Ryan Miller, Carmen Castrillo-Viguera, Kimberly Umans, Wenting Cheng, John O'Gorman, Richard Hughes, Samantha Budd Haeberlein, Christopher D Whelan
Genome-Wide Association Studies of ARIA From the Aducanumab Phase 3 ENGAGE and EMERGE Studies. Neurology 102 (3) (2023)
Melanie Shulman, Jessica Kong, John O'Gorman, Elena Ratti, Rajasimhan Rajagovindan, Louis Viollet, Ellen Huang, Sanjiv Sharma, Annie M Racine, Julie Czerkowicz, Danielle Graham, Yumeng Li, Heike Hering, Samantha Budd Haeberlein
TANGO: a placebo-controlled randomized phase 2 study of efficacy and safety of the anti-tau monoclonal antibody gosuranemab in early Alzheimer's disease. Nature aging (2023)